SHZ · EQUITY · ENHANCED MARKET DYNAMICS

300452

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.

CN · Healthcare · Drug Manufacturers - Specialty & Generic

Open Chart Terminal

EMD SCORE60/100

CURRENT COMPLETED-WEEK READ

Constructive

The balance of evidence is supportive, with some confirmation still incomplete. Conditions are positive and have strengthened over the latest four completed weeks.

Constructive build67% directional agreement89/100 evidence quality6/6 sources available

Completed week: 2 Oct 2026
Latest close: CNY 13.26
Evidence: 156 weeks

Four-week EMD change+30.3 pts

signed chart scale −100 to +100

Four-week price+3.2%

completed closing prices

Current directional run2 weeks

on the same side of EMD zero

Recent consistency2/13

recent readings above zero

COMPLETED-WEEK OVERVIEW

Price and market conditions over time

5 supportive · 1 cautious

Enhanced Market Dynamics and the price cycle156 completed weeks · bars use the left EMD axis; price uses the right axis.

22 Sep 2023–2 Oct 2026

Constructive EMDCautious EMDCompleted-week priceUp-cycle confirmationDown-cycle confirmation

Confirmation markers describe price-zone departures within this saved history. Earlier markers can change as the history changes; they are not a record of signals available in real time.

Cycle position 66%Current EMD +20.74-week EMD change +30.3Full saved history price range CNY 10.10–15.82

View chart values · 156 observations

Week	Close · CNY	EMD −100 to +100	Score /100	Agreement %	Coverage %
2023-09-22	14.39	-21.36	39	33	83
2023-09-29	14.51	-15.8	42	0	83
2023-10-13	14.72	-7.23	46	20	83
2023-10-20	13.76	-13.43	43	20	100
2023-10-27	14.19	-2.68	49	20	100
2023-11-03	14.30	-8.74	46	0	100
2023-11-10	14.48	-8.82	46	20	100
2023-11-17	14.61	5.63	53	60	100
2023-11-24	14.83	8.78	54	60	100
2023-12-01	14.64	5.38	53	50	100
2023-12-08	14.13	-6.52	47	0	100
2023-12-15	13.84	-9.76	45	0	100
2023-12-22	13.35	-19.93	40	60	100
2023-12-29	13.62	-12.05	44	20	100
2024-01-05	13.45	-18.02	41	33	100
2024-01-12	13.19	-18.6	41	20	100
2024-01-19	12.43	-32.3	34	67	100
2024-01-26	12.13	-26.27	37	33	100
2024-02-02	10.37	-47.78	26	67	100
2024-02-09	11.63	-27.38	36	33	100
2024-02-23	12.10	-26.52	37	33	100
2024-03-01	12.14	-37.71	31	67	100
2024-03-08	11.72	-35.19	32	60	100
2024-03-15	12.28	-26.76	37	50	100
2024-03-22	12.21	-32.95	34	60	100
2024-03-29	12.13	-26.61	37	50	100
2024-04-05	12.47	-15.64	42	0	100
2024-04-12	12.22	-23.59	38	50	100
2024-04-19	11.83	-27.74	36	60	100
2024-04-26	11.90	-23.02	38	50	100
2024-05-03	12.57	-7.8	46	20	100
2024-05-10	12.67	-12.6	44	20	100
2024-05-17	13.24	15.98	58	33	100
2024-05-24	12.45	-8.93	46	0	100
2024-05-31	12.45	-9.05	45	20	100
2024-06-07	11.88	-14.73	43	20	100
2024-06-14	11.88	-18.91	41	50	100
2024-06-21	11.62	-24.87	38	67	100
2024-06-28	11.08	-34.88	33	67	100
2024-07-05	10.83	-28.02	36	33	100
2024-07-12	10.79	-30.84	35	33	100
2024-07-19	10.73	-32.48	34	33	100
2024-07-26	10.39	-40.33	30	60	100
2024-08-02	10.82	-28.76	36	60	100
2024-08-09	10.81	-30.44	35	60	100
2024-08-16	10.96	-24.78	38	60	100
2024-08-23	10.28	-37.16	31	67	100
2024-08-30	10.79	-20.2	40	33	100
2024-09-06	10.42	-35.43	32	67	100
2024-09-13	10.11	-39.59	30	67	100
2024-09-20	10.10	-31.44	34	60	100
2024-09-27	11.49	-4.29	48	0	100
2024-10-04	12.79	11.16	56	60	100
2024-10-11	12.18	-0.4	50	20	100
2024-10-18	12.22	19.54	60	60	100
2024-10-25	12.18	5.22	53	20	100
2024-11-01	12.03	1.25	51	20	100
2024-11-08	12.89	30.78	65	67	100
2024-11-15	12.20	0.32	50	20	100
2024-11-22	12.00	7.96	54	20	100
2024-11-29	12.50	37.52	69	67	100
2024-12-06	12.57	31.88	66	67	100
2024-12-13	12.76	30.36	65	33	100
2024-12-20	12.56	34.81	67	60	100
2024-12-27	12.19	24.69	62	60	100
2025-01-03	11.23	2.81	51	0	100
2025-01-10	11.02	-5.37	47	50	100
2025-01-17	11.33	-11.79	44	60	100
2025-01-24	11.45	-13.29	43	50	100
2025-01-31	11.49	-8.26	46	20	100
2025-02-07	11.69	-5.02	47	20	100
2025-02-14	11.80	3.33	52	20	100
2025-02-21	11.72	-8.69	46	20	100
2025-02-28	11.12	-28.43	36	67	100
2025-03-07	11.25	-21.81	39	60	100
2025-03-14	11.50	-12.47	44	33	100
2025-03-21	11.53	-22.87	39	67	100
2025-03-28	11.67	-8.21	46	20	100
2025-04-04	11.98	8.69	54	20	100
2025-04-11	10.90	-17.39	41	50	100
2025-04-18	12.08	16.2	58	67	100
2025-04-25	11.72	-5.23	47	20	100
2025-05-02	11.63	-0.38	50	33	100
2025-05-09	11.89	8.97	54	50	100
2025-05-16	12.17	22.49	61	60	100
2025-05-23	12.40	34.53	67	100	100
2025-05-30	12.51	40.72	70	100	100
2025-06-06	12.44	27.5	64	60	100
2025-06-13	12.14	28.75	64	67	100
2025-06-20	11.75	19.47	60	50	100
2025-06-27	12.12	31.4	66	100	100
2025-07-04	14.39	69.96	85	100	100
2025-07-11	13.78	49.4	75	67	100
2025-07-18	13.98	74.45	87	100	100
2025-07-25	14.04	69.39	85	100	100
2025-08-01	14.31	54.72	77	67	100
2025-08-08	14.14	54.74	77	67	100
2025-08-15	13.99	46.43	73	67	100
2025-08-22	14.19	43.09	72	60	100
2025-08-29	13.33	22.11	61	33	100
2025-09-05	13.54	29.35	65	60	100
2025-09-12	13.55	23.55	62	60	100
2025-09-19	13.18	12.74	56	50	100
2025-09-26	12.90	7.4	54	50	100
2025-10-03	12.91	0.27	50	0	100
2025-10-10	13.03	0.62	50	0	100
2025-10-17	13.15	5.69	53	20	100
2025-10-24	13.63	10.64	55	20	100
2025-10-31	13.93	16.64	58	33	100
2025-11-07	13.88	21.93	61	60	100
2025-11-14	14.14	27.03	64	60	100
2025-11-21	13.68	5.87	53	33	100
2025-11-28	14.52	41.64	71	100	100
2025-12-05	14.20	29.49	65	60	100
2025-12-12	13.55	10.44	55	20	100
2025-12-19	13.59	21.95	61	67	100
2025-12-26	13.34	2.12	51	0	100
2026-01-02	13.38	-6.47	47	50	100
2026-01-09	13.73	1.6	51	0	100
2026-01-16	15.54	39.96	70	67	100
2026-01-23	15.69	53.6	77	67	100
2026-01-30	15.29	32.72	66	33	100
2026-02-06	15.82	48.81	74	67	100
2026-02-13	15.62	37.62	69	60	100
2026-02-27	15.79	36.32	68	33	100
2026-03-06	15.40	43.08	72	67	100
2026-03-13	15.28	31.72	66	60	100
2026-03-20	14.61	17.98	59	33	100
2026-03-27	14.87	32.21	66	67	100
2026-04-03	14.85	21.46	61	50	100
2026-04-10	14.48	10.36	55	50	100
2026-04-17	14.40	6.49	53	20	100
2026-04-24	13.52	-26.73	37	67	100
2026-05-01	13.76	-18.93	41	33	100
2026-05-08	13.75	-22.38	39	50	100
2026-05-15	13.22	-35.61	32	67	100
2026-05-22	12.55	-39.54	30	67	100
2026-05-29	12.39	-36.56	32	60	100
2026-06-05	12.19	-39.77	30	60	100
2026-06-12	12.15	-39.96	30	60	100
2026-06-19	11.91	-42.06	29	60	100
2026-06-26	11.40	-45.26	27	60	100
2026-07-03	12.46	-36.19	32	50	100
2026-07-10	12.02	-40.41	30	60	100
2026-07-17	12.47	-36.05	32	60	100
2026-07-24	11.56	-43.3	28	67	100
2026-07-31	12.14	-31.34	34	33	100
2026-08-07	12.59	-19.86	40	20	100
2026-08-14	12.95	-15.11	42	0	100
2026-08-21	12.77	-23.16	38	33	100
2026-08-28	12.93	-8.18	46	0	100
2026-09-04	12.85	-9.66	45	20	100
2026-09-11	12.60	-17.58	41	20	100
2026-09-18	12.77	-2.29	49	33	100
2026-09-25	13.12	10.36	55	60	100
2026-10-02	13.26	20.68	60	67	100

SIX SOURCES · LAST 26 OBSERVATIONS

Is support broadening or thinning?

Green is supportive, rose is cautious.
Grey means the reading is unavailable.

Reading	10 Apr	17 Apr	24 Apr	1 May	8 May	15 May	22 May	29 May	5 Jun	12 Jun	19 Jun	26 Jun	3 Jul	10 Jul	17 Jul	24 Jul	31 Jul	7 Aug	14 Aug	21 Aug	28 Aug	4 Sep	11 Sep	18 Sep	25 Sep	2 Oct
Trend	74	71	13	18	17	8	3	2	2	2	1	1	4	2	5	1	3	7	13	12	17	17	13	19	32	39
Momentum	61	64	40	42	45	36	34	30	28	29	33	27	45	38	49	43	38	53	57	68	67	62	52	60	67	65
Underlying pressure	46	40	29	21	17	14	12	11	9	8	7	6	6	7	9	10	12	18	26	41	49	56	58	59	64	70
Price & volume	48	51	36	57	53	38	38	55	51	53	48	47	53	53	42	40	59	75	65	15	45	29	13	57	53	59
Relative strength	18	10	5	5	4	2	1	1	1	2	1	1	2	3	15	6	15	13	20	23	31	41	36	37	58	74
Modeled Trend	89	89	88	87	86	84	80	78	75	72	69	66	63	61	58	57	58	57	56	57	58	58	59	60	61	62

Each cell is a finished component score from 0–100. Components can disagree even when the combined reading stays positive.

STRONGEST CURRENT SOURCE

Relative strength

74/100

LEAST SUPPORTIVE SOURCE

Trend

39/100

WHAT WOULD CHANGE THE READ?

Three paths to keep in view

Conditional research scenarios.
No assumed price target or timing.

Continuation

Price and evidence stay together

Look for the current direction to hold across trend, pressure and relative strength. A rising price with weaker EMD is a less convincing continuation.

Change of direction

Watch for loss of support

If price keeps rising while EMD falls, inspect which readings are weakening. Broad deterioration matters more than a single soft week.

Cycle context

A range extreme is a location

An upper zone can persist during a strong advance; a lower zone can persist during a decline. Use departures, EMD direction and the related price charts together.

EARLIER COMPARABLE READINGS

What followed similar conditions?

Same ticker · similar score and direction of change.
Returns exclude costs and dividends.

4 WEEKS LATER-2.6%

Median price return · 11 non-overlapping examples

Observed range: -10.6% to +15.7%
Positive returns: 36%
All-period comparison: -1.0% median

13 WEEKS LATER+3.1%

Median price return · 5 non-overlapping examples

Observed range: -17.2% to +15.1%
Positive returns: 60%
All-period comparison: +1.3% median

How these comparisons are selected

Earlier observations must have the same constructive/fading/repair/deterioration condition, a score within ten points of today’s score and at least the same component coverage. The first 30 observations are omitted for warm-up; examples are spaced by the forward horizon to avoid overlap. Gapped return windows are excluded. The all-period comparison uses the same available history and spacing, without matching the current state. These are reconstructed observations, not a point-in-time strategy backtest or a forecast.

RECENT CYCLE HISTORY

How the current reading developed

24 Apr 2026Down-cycle confirmedCNY 13.52

12 Dec 2025Down-cycle confirmedCNY 13.55

29 Aug 2025Down-cycle confirmedCNY 13.33

4 Jul 2025Upper cycle zone confirmedCNY 14.39

27 Sep 2024Up-cycle confirmedCNY 11.49

3 May 2024Up-cycle confirmedCNY 12.57

26 Apr 2024Lower cycle zone confirmedCNY 11.90

THE FULL PRICE CYCLE

Follow the journey from one zone to the other

Cycle states use trailing completed-week observations.

Lower zone

Price establishes residence near the bottom of its long-cycle range. Improving EMD separates early repair from continued deterioration.

Upward journey

Price leaves the lower zone while EMD confirms improving participation. The objective is the broader move toward the upper zone, not a short weekly trade.

Upper zone

Price establishes residence near the top of its long-cycle range. A high range position can persist. Watch EMD for exhaustion and loss of support before interpreting it as a turn.

Downward journey

Price leaves the upper zone while EMD weakens. The reverse cycle remains active until lower-zone residence is confirmed again.

CURRENT READINGS